Literature DB >> 15083852

Family physician self-efficacy with screening for inherited cancer risk.

Robert Gramling1, Justin Nash, Karen Siren, Charles Eaton, Larry Culpepper.   

Abstract

BACKGROUND: Recent evidence has shown low and inconsistent rates of family history screening among generalist physicians. Little has been done to investigate the physician factors likely to mediate this behavior. We investigated family physicians' beliefs about screening their patients for inherited cancer risk, measuring their perceptions of self-efficacy and the importance of screening.
METHODS: We mailed a cross-sectional, 1-page questionnaire to all active members (691) of the Massachusetts Academy of Family Physicians, measuring their attitudes about predictive genetic cancer screening.
RESULTS: We received responses from 300 of the 691 members (43%). Although 87% believed screening to be important, less than two thirds believed they were effective in screening.
CONCLUSIONS: Many family physicians lack confidence in their ability to screen patients for a family history of cancer despite recognizing its importance to their practice.

Entities:  

Mesh:

Year:  2004        PMID: 15083852      PMCID: PMC1466652          DOI: 10.1370/afm.60

Source DB:  PubMed          Journal:  Ann Fam Med        ISSN: 1544-1709            Impact factor:   5.166


  13 in total

Review 1.  A systematic review of the literature exploring the role of primary care in genetic services.

Authors:  J Emery; E Watson; P Rose; A Andermann
Journal:  Fam Pract       Date:  1999-08       Impact factor: 2.267

2.  Guidelines for referral to a regional genetics service: GPs respond by referring more appropriate cases.

Authors:  A Lucassen; E Watson; J Harcourt; P Rose; J O'Grady
Journal:  Fam Pract       Date:  2001-04       Impact factor: 2.267

3.  Evaluation of questionnaire on cancer family history on general practice. General practitioners reassure those at low risk and refer those at high risk.

Authors:  P Rose
Journal:  BMJ       Date:  2000-01-15

4.  Evaluation of the impact of two educational interventions on GP management of familial breast/ovarian cancer cases: a cluster randomised controlled trial.

Authors:  E Watson; A Clements; P Yudkin; P Rose; C Bukach; J Mackay; A Lucassen; J Austoker
Journal:  Br J Gen Pract       Date:  2001-10       Impact factor: 5.386

5.  The role of self-efficacy in achieving health behavior change.

Authors:  V J Strecher; B M DeVellis; M H Becker; I M Rosenstock
Journal:  Health Educ Q       Date:  1986

6.  Counselling patients to make lifestyle changes: the role of physician self-efficacy, training and beliefs about causes.

Authors:  S C Thompson; L Schwankovsky; J Pitts
Journal:  Fam Pract       Date:  1993-03       Impact factor: 2.267

7.  Self-efficacy: toward a unifying theory of behavioral change.

Authors:  A Bandura
Journal:  Psychol Rev       Date:  1977-03       Impact factor: 8.934

8.  Referral of patients with a family history of breast/ovarian cancer--GPs' knowledge and expectations.

Authors:  P W Rose; E Watson; P Yudkin; J Emery; M Murphy; A Fuller; A Lucassen
Journal:  Fam Pract       Date:  2001-10       Impact factor: 2.267

9.  Family history-taking in community family practice: implications for genetic screening.

Authors:  L S Acheson; G L Wiesner; S J Zyzanski; M A Goodwin; K C Stange
Journal:  Genet Med       Date:  2000 May-Jun       Impact factor: 8.822

10.  Primary care physicians' utilization and perceptions of genetics services.

Authors:  S J Hayflick; M P Eiff; L Carpenter; J Steinberger
Journal:  Genet Med       Date:  1998 Nov-Dec       Impact factor: 8.822

View more
  23 in total

1.  Genetic cancer risk assessment in general practice: systematic review of tools available, clinician attitudes, and patient outcomes.

Authors:  Flore Laforest; Pia Kirkegaard; Baljinder Mann; Adrian Edwards
Journal:  Br J Gen Pract       Date:  2018-12-03       Impact factor: 5.386

2.  The future of family medicine? Reflections from the front lines reveal frustration and opportunity.

Authors:  Kurt C Stange
Journal:  Ann Fam Med       Date:  2004 May-Jun       Impact factor: 5.166

3.  A Follow-Up Community Survey of Knowledge and Beliefs About Cancer and Genetics.

Authors:  Shannon M Sweeney; Janice L Hastrup; Andrew Hyland; Cheryl Rivard
Journal:  J Cancer Educ       Date:  2016-06       Impact factor: 2.037

4.  The strategic defense of physician autonomy: State public health agencies as countervailing powers.

Authors:  Laura Senier; Rachael Lee; Lauren Nicoll
Journal:  Soc Sci Med       Date:  2017-06-03       Impact factor: 4.634

5.  Familial risk of cancer and knowledge and use of genetic testing.

Authors:  Heather J Baer; Phyllis Brawarsky; Michael F Murray; Jennifer S Haas
Journal:  J Gen Intern Med       Date:  2010-04-02       Impact factor: 5.128

Review 6.  Family health history: underused for actionable risk assessment.

Authors:  Geoffrey S Ginsburg; R Ryanne Wu; Lori A Orlando
Journal:  Lancet       Date:  2019-08-05       Impact factor: 79.321

7.  Primary care physician management, referral, and relations with specialists concerning patients at risk for cancer due to family history.

Authors:  M E Wood; B S Flynn; A Stockdale
Journal:  Public Health Genomics       Date:  2013-01-17       Impact factor: 2.000

8.  Primary care physicians' use of family history for cancer risk assessment.

Authors:  Brian S Flynn; Marie E Wood; Takamaru Ashikaga; Alan Stockdale; Greg S Dana; Shelly Naud
Journal:  BMC Fam Pract       Date:  2010-06-03       Impact factor: 2.497

9.  Interviews with primary care physicians regarding taking and interpreting the cancer family history.

Authors:  Marie E Wood; Alan Stockdale; Brian S Flynn
Journal:  Fam Pract       Date:  2008-09-01       Impact factor: 2.267

10.  The knowledge value-chain of genetic counseling for breast cancer: an empirical assessment of prediction and communication processes.

Authors:  Nabil Amara; Jolyane Blouin-Bougie; Jalila Jbilou; Norrin Halilem; Jacques Simard; Réjean Landry
Journal:  Fam Cancer       Date:  2016-01       Impact factor: 2.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.